Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Combinations of a tubulin polymerization inhibitor and a poly (ADP-ribose) polymerase (PARP) inhibitor for use in the treatment of cancer

US Patent 11590130 · Granted Feb 28, 2023

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →